First truly biocompatible MIGS implant from iSTAR Medical shows consistently outstanding efficacy in patients with glaucoma

Two-year final results from STAR-I trial and initial data from STAR-II European trial tout MINIject™ as a highly promising treatment WAVRE, Belgium, April 29, 2020 -- (Healthcare Sales & Marketing Network) -- iSTAR Medical SA, a clinical-stage medical ... Devices, Ophthalmology iSTAR Medical, micro-invasive glaucoma surgery, MINIject , glaucoma
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news